Close
AI in Healthcare & Pharma Summit Boston 2026

GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations

GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted...

Biocair transports plasmids for COVID-19 research in South Africa

Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI)...

Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax

Advent Srl, an IRBM company, has manufactured 13,000 doses of the novel Covid-19 vaccine candidate, ChAdOx1 nCoV-19 (now known as AZD1222). The first 4,000...

AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors

AbbVie , a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company, announced a global, strategic collaboration to develop and commercialize SHP2...

Honeywell Expedites Development and Production of Vital Vaccines and Medical Therapies with Fast Track Automation

Honeywell announced Fast Track Automation, a combination of proprietary technology innovations for the life sciences industry that enables vital vaccines, treatments and therapies to...

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received...

Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations (CEPI) will invest...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...